×
-0.104046242774566 -0.104046242774566 -0.104046242774566 -0.104046242774566 -0.104046242774566 -0.104046242774566 -0.104046242774566 -0.104046242774566
Stock impact report

DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update

DiaMedica Therapeutics Inc. - Common Stock (DMAC)  More Company Research Source: GlobeNewswire
Last diamedica therapeutics inc. - common stock earnings: 8/13 04:35 pm Check Earnings Report
PDF Phase Ib study of DM199 in Chronic Kidney Disease enrollment completeEncouraging early signals in mechanism biomarkers (NO and PGE2), Kidney function (eGFR) and urine albumin (UACR) Phase II CKD protocol submitted, trial initiation expected H2 2019 with interim analysis Q1 2020DiaMedica regains global rights to DM199 in acute ischemic stroke as a result of its termination of Chinese license agreementConference call with management tomorrow, August 14, 2019 at 7am CT MINNEAPOLIS, Aug. 13, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for kidney diseases and neurological disorders, today provided a business update and reported its financial results for the three and six months ended June 30, 2019.Clinical DevelopmentsDM199 for the Treatment of Chronic Kidney Disease     Enrollment Complete in Phase Ib Clinical Study in Patients with CKDDiaMedica has completed enrollme [Read more]
Impact snapshot Event time: DMAC
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
DMAC alerts
from News Quantified
Opt-in for
DMAC alerts

from News Quantified
Opt-in for
DMAC alerts

from News Quantified